Past Funding
- Harvard Medical School Center of Excellence Fund for Women’s Health Research Award, Mechanisms of Hot Flushes in Women with Breast Cancer: Neuroimaging of the Hormonal Changes Caused by Aromatase Inhibitor Therapy
- Eli Lilly Pharmaceuticals, Duloxetine for the Treatment of Major Depression in Postmenopausal Women, and its Impact on Physical Symptoms, Sleep and Quality of Life
- Massachusetts General Hospital Claflin Distinguished Scholar Award, Hot Flushes in Menopause and Breast Cancer Treatment: Developing the Optimal Experimental Model
- Sepracor Inc, The Efficacy of Eszopiclone 3mg Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause or Menopause
- National Alliance for Research in Schizophrenia and Depression (NARSAD), Stabilizing Estrogen and Progesterone Levels with the Oral-Contraceptive Pill to Treat Premenstrual Worsening of Depression
- Susan G. Komen Breast Cancer Foundation, Targeting Insomnia to Optimize Hot-Flush Therapy in Women with Breast Cancer
- NIMH K23 MH066978-1A1, Physiology of Estrogen’s Mood Effects in Menopausal Women
- Abbott Laboratories, The Relationship Between Valproate and Other Mood-Stabilizer Therapies to the Polycystic Ovarian Syndrome and Polycystic Ovarian Morphology in Women with Bipolar Disorder
- Ancillary study in Systematic Treatment of Bipolar Disorder (STEP-BD), NIMH, The Relationship Between Valproate and Other Mood-Stabilizer Therapies to the Polycystic Ovarian Syndrome and Polycystic Ovarian Morphology in Women with Bipolar Disorder
- NIMH 5 T32 MH1 7119, Training Program in Psychiatric Epidemiology and Biostatistics
- Harvard Medical School, 50th Anniversary Scholars in Medicine Award
- Pfizer/Society for the Advancement of Women’s Health Scholars Award, Effect of Estrogen on Memory in Non-Depressed Menopausal Women
- Kaplan Depression Research Fellowship, Depression During the Menopause Transition
